CPT31

Evidence outlook · lead readout

NCT04672083 · HIV Infections

The completed lead evidence is positive, with design limits that temper confidence — see the rationale below for exactly which.

NCT04672083: The study randomly assigned healthy volunteers to CPT31 or matching placebo and blinded participants, care providers, investigators, and outcome assessors, which are the hallmarks of a well-controlled study. It reported that no participant in any group, active or placebo, had a serious adverse event, but the study measured only safety and drug levels in healthy volunteers rather than any HIV outcome.